Allianz Asset Management
CDMO

Allianz Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Allianz Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,797
Closed -$72.3K – 2283
2024
Q1 		$72.3K Sell
10,797
-1,558
-13% -$10.7K ﹤0.01% 1945
2023
Q4 		$80.3K Buy
+12,355
New +$79.6K ﹤0.01% 2090

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Allianz Asset Management's CDMO Position: Q2 2024 in Review

Allianz Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2024, closing a stake of 10,797 shares — an estimated $72.3K sold.

Allianz Asset Management first reported a position in CDMO in Q4 2023 and held it in 2 quarters. The position peaked at $80.3K in Q4 2023. 171 funds tracked by Wall St. Rank hold CDMO as of Q2 2024.

  • Allianz Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Allianz Asset Management sold 10,797 Avid Bioservices, Inc. Common Stock shares in Q2 2024, an estimated $72.3K.
  • Allianz Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • Allianz Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $80.3K in Q4 2023.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2024.

Based on Allianz Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.